Company Information

Alnylam Pharmaceuticals, Inc.

Member Type

Associate

Organization Type

Manufacturer

Description

Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam's work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of RNAi therapeutics possible. In 2018, our first commercial medicine, and the world's first RNAi therapeutic was approved. Since then, five more Alnylam developed medicines have been approved and we're hard at work developing new therapies to treat both rare and prevalent diseases.

Contact Information

300 Third Street, 3rd Floor

Cambridge, MA 02142

http://www.alnylam.com/

(617)551-8200

Services Offered

Branded

Staff

  • DiPrimio, Jeff

    Director, Corporate Security, Alnylam Pharmaceuticals, Inc.

  • Eisenberg, Alan

    Vice President, Public Policy & Government Relations, Alnylam Pharmaceuticals, Inc.

  • Komara, Greg

    Director, Channel Distribution, Alnylam Pharmaceuticals, Inc.

  • Lasko, Rhonda

    Sr. Director, US Channel Distribution, Alnylam Pharmaceuticals, Inc.

  • Parsons, Deirdre

    Senior Manager, Public Policy & Government Relations, Alnylam Pharmaceuticals, Inc.
Start a New Company Search